Navigating Complexities of Tumor Heterogeneity: The Role of Cancer Research LIMS in Advancing Precision Oncology
Cancer treatment has come a long way, yet relapse remains a major challenge—often leading to more aggressive disease. One key reason? Tumor heterogeneity. Differences within and between tumors can drive drug resistance, making standard treatments less effective.
In our latest blog, we explore:
- Causes of tumor heterogeneity
- How tumor heterogeneity causes drug resistance and treatment failure
- Latest technologies for unraveling tumor heterogeneity
- How a LIMS enables labs to advance cancer research and improve patient outcomes

Comments
Post a Comment